Lina M. Echeverria-Carmona

43-45 Foley St, London W1W 7TS
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.

Journal: Radiology
Published: December 13, 2022

Exploring the Value of BRD9 as a Biomarker, Therapeutic Target and Co-Target in Prostate Cancer.

Exploring the Value of BRD9 as a Biomarker, Therapeutic Target and Co-Target in Prostate Cancer.

Journal: Biomolecules
Published: September 03, 2021

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.

Evaluation of PSA and PSA Density in a Multiparametric Magnetic Resonance Imaging-Directed Diagnostic Pathway for Suspected Prostate Cancer: The INNOVATE Trial.

Journal: Cancers
Published: March 05, 2021

Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out.

Conspicuity of cribriform prostate cancer on multiparametric magnetic resonance imaging: the jury is still out.

Journal: BJU international
Published: November 13, 2020

Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.

Histopathological features of prostate cancer conspicuity on multiparametric MRI: protocol for a systematic review and meta-analysis.

Journal: BMJ open
Published: October 23, 2020

A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.

A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists.

Journal: Scientific reports
Published: April 30, 2020

Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features.

Prostate cancer visibility on multiparametric magnetic resonance imaging: high Gleason grade and increased tumour volume are not the only important histopathological features.

Journal: BJU international
Published: April 15, 2020

Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.

Re: Gregory T. Chesnut, Emily A. Vertosick, Nicole Benfante, et al. Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. Eur Urol 2020;77:501-7.

Journal: European urology
Published: April 07, 2020

What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.

What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.

Journal: European urology
Published: January 12, 2020

Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.

Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.

Journal: The Prostate
Published: February 28, 2018

Bone scan is of doubtful value as a first staging test in the primary presentation of prostate cancer.

Bone scan is of doubtful value as a first staging test in the primary presentation of prostate cancer.

Journal: ISRN oncology
Published: September 03, 2012
Showing 1-11 of 11

Last Updated: 09/26/2026